Milk Free From A1-Type β-Casein on Inflammation, Gastrointestinal Tolerance, and Pregnancy Outcomes

NARecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

August 25, 2025

Primary Completion Date

September 30, 2026

Study Completion Date

September 30, 2026

Conditions
Healthy Pregnant Women
Interventions
OTHER

a2 UHT milk

Pregnant women in this arm will drink a2 UHT Milk twice a day, 200ml each time, until study completion. Their infants will be fed with the mother's breastmilk exclusively.

OTHER

Conventional UHT Milk

Pregnant women in this arm will drink conventional UHT Milk twice a day, 200ml each time, until study completion. Their infants will be fed with the mother's breastmilk exclusively.

Trial Locations (5)

214002

RECRUITING

Wuxi Maternal and Child Health Hospital, Wuxi

214122

RECRUITING

Affiliated hospital of Jiangnan University, Wuxi

221009

RECRUITING

Xuzhou Maternal and Child Health Hospital, Xuzhou

511400

RECRUITING

Panyu Maternal and Child Care Service Centre of Guangzhou, Guangzhou

610041

RECRUITING

First People's Hospital of Chengdu, Chengdu

All Listed Sponsors
collaborator

Edanz Inc

UNKNOWN

collaborator

Cyanth (Wuxi) Health Technology Co. Ltd.

UNKNOWN

collaborator

Affilicated Hospital of Jiangnan University

UNKNOWN

collaborator

Guangzhou Trials Medical

UNKNOWN

lead

a2 Milk Company Ltd.

INDUSTRY